Prostate Cancer - Results from #26620

Benefits, barriers, sources of influence, and prostate cancer screening among rural men - Abstract December 16, 2011

PS2-25:Prostate cancer screening: Benefits, barriers and conflicting information - Abstract December 15, 2011

Prostate cancer in a young adult : A case report - Abstract December 15, 2011

Usefulness of MRI prior to prostate needle biopsy in PSA gray zone - Abstract December 15, 2011

The dosimetric effect of mixed-energy IMRT plans for prostate cancer - Abstract December 15, 2011

Increased risk of cancer among gout patients: A nationwide population study - Abstract December 15, 2011

Metastatic prostate carcinoma mimicking primary anal cancer - Abstract December 15, 2011

Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men - Abstract December 15, 2011

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial - Abstract December 15, 2011

High dose brachytherapy as monotherapy for intermediate risk prostate cancer - Abstract December 14, 2011

The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population - Abstract December 14, 2011

Utilization trends at a multidisciplinary prostate cancer clinic: Initial 5-year experience from the Duke Prostate Center - Abstract December 14, 2011

Atrophy of the tongue as the presenting feature of metastatic prostate cancer - Abstract December 14, 2011

Solitary testicular metastasis of prostate cancer mimicking primary testicular cancer - Abstract December 14, 2011

Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions - Abstract December 14, 2011

Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: Analysis of a single-center series of patients with a minimum follow-up of 5 years - Abstract December 14, 2011

MR imaging of prostate cancer: Diffusion weighted imaging and (3D) hydrogen 1 (H) MR spectroscopy in comparison with histology - Abstract December 14, 2011

Locally advanced prostate cancer: A population-based study of treatment patterns - Abstract December 13, 2011

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer - Abstract December 13, 2011

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume - Abstract December 13, 2011

Page 1332 of 1436